loadpatents
name:-0.040013074874878
name:-0.02669095993042
name:-0.0017919540405273
King; C. Richter Patent Filings

King; C. Richter

Patent Applications and Registrations

Patent applications and USPTO patent grants for King; C. Richter.The latest application filed is for "modified serotype 28 adenoviral vectors".

Company Profile
0.27.37
  • King; C. Richter - New York NY
  • King; C. Richter - Washington DC
  • King; C. Richter - Gaithersburg MD
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Modified Serotype 28 Adenoviral Vectors
App 20210269827 - Wei; Lisa ;   et al.
2021-09-02
Modified serotype 28 adenoviral vectors
Grant 10,947,560 - Wei , et al. March 16, 2
2021-03-16
Method for propagating adenoviral vectors encoding inhibitory gene products
Grant 10,640,776 - Gall , et al.
2020-05-05
Method For Propagating Adenoviral Vectors Encoding Inhibitory Gene Products
App 20180223290 - Gall; Jason G.D. ;   et al.
2018-08-09
Modified Serotype 28 Adenoviral Vectors
App 20180100164 - Wei; Lisa ;   et al.
2018-04-12
Modified serotype 28 adenoviral vectors
Grant 9,790,519 - Wei , et al. October 17, 2
2017-10-17
HIV-1 envelope glycoprotein
Grant 9,738,688 - Caulfield , et al. August 22, 2
2017-08-22
Malaria antigen screening method
Grant 9,651,543 - Bruder , et al. May 16, 2
2017-05-16
Malaria Antigen Screening Method
App 20170082607 - Bruder; Joseph T. ;   et al.
2017-03-23
Method For Propagating Adenoviral Vectors Encoding Inhibitory Gene Products
App 20160304882 - Gall; Jason G.D. ;   et al.
2016-10-20
Method for propagating adenoviral vectors encoding inhibitory gene products
Grant 9,388,429 - Gall , et al. July 12, 2
2016-07-12
Adenoviral vector-based malaria vaccines
Grant 9,254,316 - Bruder , et al. February 9, 2
2016-02-09
Modified Serotype 28 Adenoviral Vectors
App 20150167018 - Wei; Lisa ;   et al.
2015-06-18
Methods Of Identifying Novel Hiv-1 Immunogens
App 20150065381 - HOFFENBERG; SIMON ;   et al.
2015-03-05
Adenoviral Vector-based Malaria Vaccines
App 20140335128 - Bruder; Joseph T. ;   et al.
2014-11-13
Malaria Antigen Screening Method
App 20140314809 - Bruder; Joseph T. ;   et al.
2014-10-23
Method For Propagating Adenoviral Vectors Encoding Inhibitory Gene Products
App 20140273228 - Gall; Jason G.D. ;   et al.
2014-09-18
Novel Hiv-1 Envelope Glycoprotein
App 20140212458 - Caulfield; Michael ;   et al.
2014-07-31
Adenoviral vector-based malaria vaccines
Grant 8,765,146 - Bruder , et al. July 1, 2
2014-07-01
Method for inducing a multiclade immune response against HIV utilizing a multigene and multiclade immunogen
Grant 8,454,972 - Nabel , et al. June 4, 2
2013-06-04
Malaria antigen screening method
Grant 8,450,055 - Bruder , et al. May 28, 2
2013-05-28
Adenoviral vector-based foot-and-mouth disease vaccine
Grant 8,323,663 - Brough , et al. December 4, 2
2012-12-04
HIV vaccines based on adenoviral vectors encoding Env from multiple clades of HIV
Grant 8,323,961 - Nabel , et al. December 4, 2
2012-12-04
Method Of Using Adenoviral Vectors To Induce An Immune Response
App 20120302627 - Nabel; Gary J. ;   et al.
2012-11-29
Hiv Vaccines Based On Env Of Multiple Clades Of Hiv
App 20110274721 - Nabel; Gary J. ;   et al.
2011-11-10
Method For Improving The Breadth Of The Immune Response To Diverse Strains And Clades Of Hiv
App 20110200636 - Nabel; Gary J. ;   et al.
2011-08-18
Human gene related to but distinct from EGF receptor gene
Grant 7,838,216 - King , et al. November 23, 2
2010-11-23
Adenoviral Vector-based Malaria Vaccines
App 20100278870 - Bruder; Joseph T. ;   et al.
2010-11-04
Malaria antigen screening method
App 20100222234 - Bruder; Joseph T. ;   et al.
2010-09-02
Method of using adenoviral vectors to induce an immune response
App 20090286860 - Nabel; Gary J. ;   et al.
2009-11-19
Adenoviral vector-based foot-and-mouth disease vaccine
App 20090264509 - Brough; Douglas E. ;   et al.
2009-10-22
Vaccines against aids comprising cmv/r-nucleic acid constructs
App 20090214588 - Nabel; Gary J. ;   et al.
2009-08-27
Adenoviral Vector-based Malaria Vaccines
App 20090148477 - Bruder; Joseph T. ;   et al.
2009-06-11
Methods of regulating angiogenesis through stabilization of PEDF
App 20090149381 - Reiter; Christopher ;   et al.
2009-06-11
Heregulin-like Factor
App 20080254466 - Young; Paul E. ;   et al.
2008-10-16
Adenoviral Vector-based Malaria Vaccines
App 20080248060 - Bruder; Joseph T. ;   et al.
2008-10-09
Method for propagating adenoviral vectors encoding inhibitory gene products
App 20080233650 - Gall; Jason G. D. ;   et al.
2008-09-25
Redox-stable, Non-phosphorylated Cyclic Peptide Inhibitors Of Sh2 Domain Binding To Target Protein, Conjugates, Thereof, Compositions And Methods Of Synthesis And Use
App 20080031812 - Roller; Peter P. ;   et al.
2008-02-07
Adenovirus Fiber Shaft Composition And Methods Of Use
App 20080003236 - King; C. Richter ;   et al.
2008-01-03
Methods Of Regulating Angiogenisis Through Stabilization Of Pedf
App 20070232541 - Reiter; Christopher ;   et al.
2007-10-04
Method of Using Adenoviral Vectors to Induce an Immune Response
App 20070207166 - Nabel; Gary J. ;   et al.
2007-09-06
Redox-stable, non-phosphorylated cyclic peptide inhibitors of SH2 domain binding to target protein, conjugates thereof, compositions and methods of synthesis and use
Grant 7,259,142 - Roller , et al. August 21, 2
2007-08-21
Adenoviral vector-based vaccines
App 20060286121 - Gall; Jason G. D. ;   et al.
2006-12-21
Heregulin-like factor
App 20060141522 - Young; Paul E. ;   et al.
2006-06-29
Heregulin-like factor antibodies
Grant 7,049,409 - Young , et al. May 23, 2
2006-05-23
Redox-stable, non-phosphorylated cyclic peptide inhibitors of SH2 domain binding to target protein, conjugates thereof, compositions and methods of synthesis and use
App 20060014927 - Roller; Peter P. ;   et al.
2006-01-19
Redox-stable, non-phosphorylated cyclic peptide inhibitors of SH2 domain binding to target protein, conjugates thereof, compositions and methods of synthesis and use
Grant 6,951,915 - Roller , et al. October 4, 2
2005-10-04
Heregulin-like factor
Grant 6,727,077 - Young , et al. April 27, 2
2004-04-27
Heregulin-like factor
App 20040048295 - Young, Paul E. ;   et al.
2004-03-11
Anti-erbB-2 antibodies to human receptor related to but distinct from EGF receptor
Grant 6,653,084 - King , et al. November 25, 2
2003-11-25
Replication deficient adenoviral TNF vector
App 20030175245 - Brough, Douglas E. ;   et al.
2003-09-18
Redox-stable, non-phosphorylated cyclic peptide inhibitors of SH2 domain binding to target protein, conjugates thereof, compositions and methods of synthesis and use
App 20030078368 - Roller, Peter P. ;   et al.
2003-04-24
Acylated oligopeptide derivatives having cell signal inhibiting activity
Grant 6,307,090 - Burke, Jr. , et al. October 23, 2
2001-10-23
erbB-2 gene segments, probes, recombinant DNA and kits for detection
Grant 5,985,553 - King , et al. November 16, 1
1999-11-16
Protein related to but distinct from EGF receptor and antibodies reactive therewith
Grant 5,747,261 - King , et al. May 5, 1
1998-05-05
Anti-erbB-2 antibodies, combinations thereof, and therapeutic and diagnostic uses thereof
Grant 5,587,458 - King , et al. Dec
1996-12-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed